uniQure N.V’s recently made public that its CEO, Managing Director Kapusta Matthew C unloaded Company’s shares for reported $0.29 million on Mar 04 ’25. In the deal valued at $10.29 per share,28,341 shares were sold. As a result of this transaction, Kapusta Matthew C now holds 651,454 shares worth roughly $9.84 million.
Then, Abi-Saab Walid sold 1,350 shares, generating $13,891 in total proceeds. Upon selling the shares at $10.29, the Chief Medical Officer now owns 151,903 shares.
Before that, KLEMT CHRISTIAN sold 10,438 shares. uniQure N.V shares valued at $107,407 were divested by the Chief Financial Officer at a price of $10.29 per share. As a result of the transaction, KLEMT CHRISTIAN now holds 217,730 shares, worth roughly $3.29 million.
A number of analysts have revised their coverage, including Raymond James’s analysts, who increased its forecast for the stock in early December from “an Outperform” to “a Strong buy”. Goldman revised its rating on February 29, 2024. It rated QURE as “a Neutral” which previously was an “a Buy”.
Price Performance Review of QURE
On Monday, uniQure N.V [NASDAQ:QURE] saw its stock fall -1.50% to $15.11. Over the last five days, the stock has lost -10.59%. uniQure N.V shares have fallen nearly -14.44% since the year began. Nevertheless, the stocks have risen 186.17% over the past one year. While a 52-week high of $19.18 was reached on 01/07/25, a 52-week low of $3.73 was recorded on 04/09/25.
Levels Of Support And Resistance For QURE Stock
The 24-hour chart illustrates a support level at 14.80, which if violated will result in even more drops to 14.49. On the upside, there is a resistance level at 15.46. A further resistance level may holdings at 15.81.
